Comparison of poliovirus recombinants: Accumulation of point mutations provides further advantages

Journal of General Virology

Volumn 90, Issue 8, 2009, Pages 1859-1868

  Savolainen Kopra, Carita ^a   Samoilovich, Elena ^b   Kahelin, Heidi ^a   Hiekka, Anna Kaisa ^a   Hovi, Tapani ^a   Roivainen, Merja ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Research Institute for Epidemiology & Microbiology RIEM   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; HELA CELL; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; VIRAL GENETICS; VIROGENESIS; VIRUS GENOME; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN; ADAPTATION; AMINO ACID SUBSTITUTION; CELL LINE; CHILD; DNA SEQUENCE; GENETIC RECOMBINATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS; PATHOGENICITY; VIRULENCE; VIRUS CULTURE;

POLIOVIRUS;

CAPSID PROTEIN; ORAL POLIOMYELITIS VACCINE; VP1 PROTEIN, POLIOVIRUS;

ADAPTATION, BIOLOGICAL; AMINO ACID SUBSTITUTION; CAPSID PROTEINS; CELL LINE; CHILD; GENOME, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PLAQUE ASSAY; POINT MUTATION; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 69449098248     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.010942-0     Document Type: Article

References (53)

1. Agol, V. I. (1997). Recombination and other genomic rearrangements in picornaviruses. Semin Virol 8, 77-84.
2. Agol, V. I. (2006). Vaccine-derived polioviruses. Biologicals 34, 103-108.
3. Arita, M., Zhu, S. L., Yoshida, H., Yoneyama, T., Miyamura, T. & Shimizu, H. (2005). A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol 79, 12650-12657.
4. Blomqvist, S., Bruu, A. L., Stenvik, M. & Hovi, T. (2003). Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol 84, 573-580.
5. Blomqvist, S., Savolainen, C., Laine, P., Hirttio, P., Lamminsalo, E., Penttila, E., Joks, S., Roivainen, M. & Hovi, T. (2004). Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol 78, 4876-4883.
6. Bolanaki, E., Kottaridi, C., Markoulatos, P., Kyriakopoulou, Z., Margaritis, L. & Katsorchis, T. (2007). Partial 3D gene sequences of Coxsackie viruses reveal interspecies exchanges. Virus Genes 35, 129-140.
7. Brown, B., Oberste, M. S., Maher, K. & Pallansch, M. A. (2003). Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol 77, 8973-8984.
8. Cammack, N., Phillips, A., Dunn, G., Patel, V. & Minor, P. D. (1988). Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology 167, 507-514.
9. Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R. & other authors (2005). Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol 79, 1062-1070.
10. Dahourou, G., Guillot, S., Le Gall, O. & Crainic, R. (2002). Genetic recombination in wild-type poliovirus. J Gen Virol 83, 3103-3110.
11. Dedepsidis, E., Pliaka, V., Kyriakopoulou, Z., Brakoulias, C., Levidiotou-Stefanou, S., Pratti, A., Mamuris, Z. & Markoulatos, P. (2008). Complete genomic characterization of an intertypic Sabin 3/ Sabin 2 capsid recombinant. FEMS Immunol Med Microbiol 52, 343-351.
12. El Bassioni, L., Barakat, I., Nasr, E., de Gourville, E. M., Hovi, T., Blomqvist, S., Burns, C., Stenvik, M., Gary, H. & other authors (2003). Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am J Epidemiol 158, 807-815.
13. Furione, M., Guillot, S., Otelea, D., Balanant, J., Candrea, A. & Crainic, R. (1993). Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology 196, 199-208.
14. Georgescu, M. M., Delpeyroux, F. & Crainic, R. (1995). Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus. J Gen Virol 76, 2343-2348.
15. Gmyl, A. P., Belousov, E. V., Maslova, S. V., Khitrina, E. V., Chetverin, A. B. & Agol, V. I. (1999). Nonreplicative RNA recombination in poliovirus. J Virol 73, 8958-8965.
16. Goodfellow, I., Chaudhry, Y., Richardson, A., Meredith, J., Almond, J. W., Barclay, W. & Evans, D. J. (2000). Identification of a cis-acting replication element within the poliovirus coding region. J Virol 74, 4590-4600.
17. Guillot, S., Caro, V., Cuervo, N., Korotkova, E., Combiescu, M., Persu, A., Aubert-Combiescu, A., Delpeyroux, F. & Crainic, R. (2000). Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74, 8434-8443.
18. Hirst, G. K. (1962). Genetic recombination with Newcastle disease virus, polioviruses, and influenza. Cold Spring Harb Symp Quant Biol 27, 303-309.
19. Hogle, J. M., Chow, M. & Filman, D. J. (1985). Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229, 1358-1365.
20. Jiang, P., Faase, J. A., Toyoda, H., Paul, A., Wimmer, E. & Gorbalenya, A. E. (2007). Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci U S A 104, 9457-9462.
21. Johnson, V. H. & Semler, B. L. (1988). Defined recombinants of poliovirus and coxsackievirus: sequence-specific deletions and functional substitutions in the 5′-noncoding regions of viral RNAs. Virology 162, 47-57.
22. Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J. & other authors (2002). Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296, 356-359.
23. Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N. & Pallansch, M. A. (2004). Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82, 16-23.
24. Kok, C. C. & McMinn, P. C. (2009). Picornavirus RNA-dependent RNA polymerase. Int J Biochem Cell Biol 41, 498-502.
25. Kyriakopoulou, Z., Kottaridi, C., Dedepsidis, E., Bolanaki, E., Levidiotou-Stefanou, S. & Markoulatos, P. (2006). Molecular characterization of wild-type polioviruses isolated in Greece during the 1996 outbreak in Albania. J Clin Microbiol 44, 1150-1152.
26. Lai, M. M. (1992). RNA recombination in animal and plant viruses. Microbiol Rev 56, 61-79.
27. Ledinko, N. (1963). Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology 20, 107-119.
28. Liu, H. M., Zheng, D. P., Zhang, L. B., Oberste, M. S., Pallansch, M. A. & Kew, O. M. (2000). Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74, 11153-11161.
29. Liu, H. M., Zheng, D. P., Zhang, L. B., Oberste, M. S., Kew, O. M. & Pallansch, M. A. (2003). Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol 77, 10994-11005.
30. Lole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W. & Ray, S. C. (1999). Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73, 152-160.
31. Lu, H. H. & Wimmer, E. (1996). Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A 93, 1412-1417.
32. Macadam, A. J., Arnold, C., Howlett, J., John, A., Marsden, S., Taffs, F., Reeve, P., Hamada, N., Wareham, K. & other authors (1989). Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172, 408-414.
33. Macadam, A. J., Pollard, S. R., Ferguson, G., Dunn, G., Skuce, R., Almond, J. W. & Minor, P. D. (1991). The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity. Virology 181, 451-458.
34. Martin, J., Dunn, G., Hull, R., Patel, V. & Minor, P. D. (2000). Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74, 3001-3010.
35. Martin, J., Samoilovich, E., Dunn, G., Lackenby, A., Feldman, E., Heath, A., Svirchevskaya, E., Cooper, G., Yermalovich, M. & Minor, P. D. (2002). Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis. J Virol 76, 10921-10928.
36. Minor, P. D., Ferguson, M., Evans, D. M., Almond, J. W. & Icenogle, J. P. (1986a). Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67, 1283-1291.
37. Minor, P. D., John, A., Ferguson, M. & Icenogle, J. P. (1986b). Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol 67, 693-706.
38. Minor, P. D., Dunn, G., Evans, D. M., Magrath, D. I., John, A., Howlett, J., Phillips, A., Westrop, G., Wareham, K. & other authors (1989). The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. J Gen Virol 70, 1117-1123.
39. Mulders, M. N., Reimerink, J. H., Stenvik, M., Alaeddinoglu, I., van der Avoort, H. G., Hovi, T. & Koopmans, M. P. (1999). A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol 80, 907-916.
40. Oberste, M. S., Maher, K., Kilpatrick, D. R., Flemister, M. R., Brown, B. A. & Pallansch, M. A. (1999). Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 37, 1288-1293.
41. Pulli, T., Koskimies, P. & Hyypia, T. (1995). Molecular comparison of coxsackie A virus serotypes. Virology 212, 30-38.
42. Rakoto-Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L. & other authors (2008). Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 197, 1427-1435.
43. Ren, R. B., Moss, E. G. & Racaniello, V. R. (1991). Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol 65, 1377-1382.
44. Rieder, E., Xiang, W., Paul, A. & Wimmer, E. (2003). Analysis of the cloverleaf element in a human rhinovirus type 14/poliovirus chimera: correlation of subdomain D structure, ternary protein complex formation and virus replication. J Gen Virol 84, 2203-2216.
45. Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclere, P. & Delpeyroux, F. (2003). Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 9, 885-887.
46. Samoilovich, E., Roivainen, M., Titov, L. P. & Hovi, T. (2003). Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children. J Med Virol 71, 274-280.
47. Shahmahmoodi, S., Parvaneh, N., Burns, C., Asghar, H., Mamishi, S., Tabatabaie, H., Chen, Q., Teimourian, S., Gooya, M. M. & other authors (2008). Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res 137, 168-172.
48. Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M. & other authors (2004). Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78, 13512-13521.
49. Stanway, G. & Knowles, N. J. (2008). Taxonomic proposal to the ICTV executive committee to merge two existing species. http://talk.ictvonline.org/media/p/233.aspx
50. Thompson, A. A. & Peersen, O. B. (2004). Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J 23, 3462-3471.
51. Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F. & Higgins, D. G. (1997). The CLUSTAL_X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25, 4876-4882.
52. Westrop, G. D., Wareham, K. A., Evans, D. M., Dunn, G., Minor, P. D., Magrath, D. I., Taffs, F., Marsden, S., Skinner, M. A. & other authors (1989). Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol 63, 1338-1344.
53. Yang, C. F., Naguib, T., Yang, S. J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H. & other authors (2003). Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 77, 8366-8377.